BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng G, Yang Y, Xu Z, Liu J, Hou W, Wang X, Li Z, Deng L, Wang S, Li J, Han Q, Li H, Shan G, Cao Y, An X, Yan J, Zhang Z, Li H, Qu X, Zhu J, Zhou S, Wang J, Zhang F, Gao J, Jin R, Xu D, Ma YQ, Huang T, Peng S, Zheng Z, Stambler I, Gilson E, Lim LW, Moskalev A, Cano A, Chakrabarti S, Ulfhake B, Su H, Xu H, Xu S, Wei F, Brown-Borg HM, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. Cell Res 2021. [PMID: 34702946 DOI: 10.1038/s41422-021-00573-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Qi W, Dong N, Wu L, Zhang X, Li H, Wu H, Ward N, Yu J, Liu H, Wang J, Deng X, Zhao RC. Promoting oral mucosal wound healing using a DCS-RuB2A2 hydrogel based on a photoreactive antibacterial and sustained release of BMSCs. Bioactive Materials 2023;23:53-68. [DOI: 10.1016/j.bioactmat.2022.10.027] [Reference Citation Analysis]
2 Yao M, Chen Z, He X, Long J, Xia X, Li Z, Yang Y, Ao L, Xing W, Lian Q, Liang H, Xu X. Cross talk between glucose metabolism and immunosuppression in IFN-γ–primed mesenchymal stem cells. Life Sci Alliance 2022;5:e202201493. [DOI: 10.26508/lsa.202201493] [Reference Citation Analysis]
3 Grumet M, Sherman J, Dorf BS. Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study. Stem Cells Transl Med 2022:szac067. [PMID: 36181766 DOI: 10.1093/stcltm/szac067] [Reference Citation Analysis]
4 Feng XD, Zhou JH, Chen JY, Feng B, Hu RT, Wu J, Pan QL, Yang JF, Yu J, Cao HC. Long non-coding RNA SNHG16 promotes human placenta-derived mesenchymal stem cell proliferation capacity through the PI3K/AKT pathway under hypoxia. World J Stem Cells 2022; 14(9): 714-728 [DOI: 10.4252/wjsc.v14.i9.714] [Reference Citation Analysis]
5 Chen C, Chang K, Lin Y, Ho M, Cheng M, Shih W, Chou C, Lin P, Chi C, Lu M, Tien N, Wu M, Chang S, Hsu W, Shyu W, Cho D, Jeng L. Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1001979] [Reference Citation Analysis]
6 Yao W, Dong H, Qi J, Zhang Y, Shi L. Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2022;51:101545. [PMID: 35844767 DOI: 10.1016/j.eclinm.2022.101545] [Reference Citation Analysis]
7 Tsermpini EE, Glamočlija U, Ulucan-Karnak F, Redenšek Trampuž S, Dolžan V. Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review. Antioxidants (Basel) 2022;11:1609. [PMID: 36009328 DOI: 10.3390/antiox11081609] [Reference Citation Analysis]
8 Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022;7:272. [PMID: 35933430 DOI: 10.1038/s41392-022-01134-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Weiss DJ, Filiano A, Galipeau J, Khoury M, Krampera M, Lalu M, Blanc KL, Nolta J, Phinney DG, Rocco PR, Shi Y, Tarte K, Viswanathan S, Martin I. An ISCT MSC Committee Editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for COVID-19: Time for a global registry. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2022.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tan C, Tan S, Zhang H, Zhang M, Fan H, Nan Z, Liu X, Wang W, Zhang L, Deng S, Zuo D, Tang Q. Enhanced migration and immunoregulatory capacity of BMSCs mediated by overexpression of CXCR4 and IL-35. Mol Immunol 2022;150:1-8. [PMID: 35908411 DOI: 10.1016/j.molimm.2022.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Caruso C, Ligotti ME, Accardi G, Aiello A, Candore G. An immunologist's guide to immunosenescence and its treatment. Expert Rev Clin Immunol 2022. [PMID: 35876758 DOI: 10.1080/1744666X.2022.2106217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yang Y, Zhao RC, Zhang F. Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives. Front Cell Dev Biol 2022;10:933565. [DOI: 10.3389/fcell.2022.933565] [Reference Citation Analysis]
13 Zhang M, Yan X, Shi M, Li R, Pi Z, Ren X, Wang Y, Yan S, Wang Y, Jin Y, Wang X. Safety and efficiency of stem cell therapy for COVID-19: a systematic review and meta-analysis. Glob Health Res Policy 2022;7:19. [PMID: 35733229 DOI: 10.1186/s41256-022-00251-5] [Reference Citation Analysis]
14 Chen P, Zhou YK, Han CS, Chen LJ, Wang YM, Zhuang ZM, Lin S, Zhou YH, Jiang JH, Yang RL. Stem Cells From Human Exfoliated Deciduous Teeth Alleviate Liver Cirrhosis via Inhibition of Gasdermin D-Executed Hepatocyte Pyroptosis. Front Immunol 2022;13:860225. [PMID: 35634294 DOI: 10.3389/fimmu.2022.860225] [Reference Citation Analysis]
15 Keating A. Treatment of COVID-19 with MSCs: how does it work? Sci China Life Sci 2022;65:849-850. [DOI: 10.1007/s11427-021-2022-5] [Reference Citation Analysis]
16 Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther 2022;13:122. [PMID: 35313959 DOI: 10.1186/s13287-022-02796-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chutipongtanate S, Kongsomros S, Pongsakul N, Panachan J, Khowawisetsut L, Pattanapanyasat K, Hongeng S, Thitithanyanont A. Anti-SARS-CoV-2 effect of extracellular vesicles released from mesenchymal stem cells. J Extracell Vesicles 2022;11:e12201. [PMID: 35289102 DOI: 10.1002/jev2.12201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Barnoud C, Wang C, Scheiermann C. Timing vaccination against SARS-CoV-2. Cell Res 2021;31:1146-7. [PMID: 34471238 DOI: 10.1038/s41422-021-00559-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]